Barriers to recommended gynecologic care in an urban United States HIV clinic

Journal of Women's Health

Volumn 19, Issue 8, 2010, Pages 1511-1518

  Tello, Monique A ^a   Jenckes, Mollie ^b   Gaver, Jennifer ^b   Anderson, Jean R ^b   Moore, Richard D ^b   Chander, Geetanjali ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACADEMIC ACHIEVEMENT; ADULT; ARTICLE; DEPRESSION; FEAR; FEMALE; GYNECOLOGIC CARE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; OUTPATIENT DEPARTMENT; PAPANICOLAOU TEST; PATIENT COMPLIANCE; PRIORITY JOURNAL; RISK FACTOR; SUBSTANCE ABUSE; UNITED STATES; URBAN AREA; WEATHER;

ADULT; CROSS-SECTIONAL STUDIES; FEMALE; FOCUS GROUPS; GYNECOLOGY; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HIV SEROPOSITIVITY; HUMANS; LOGISTIC MODELS; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; SOCIOECONOMIC FACTORS; UNITED STATES; URBAN HEALTH SERVICES;

EID: 77955243732     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2009.1670     Document Type: Article

References (39)

1. Korn AP. Gynecologic care of women infected with HIV. Clin Obstet Gynecol 2001;44:226-242.
2. Cejtin HE. Gynecologic issues in the HIV-infected woman. Obstet Gynecol Clin North Am 2003;30:711-729.
3. Jamieson DJ, Paramsothy P, Cu-Uvin S, Duerr A. Vulvar, vaginal, and perianal intraepithelial neoplasia in women with or at risk for HIV. Obstet Gynecol 2006;107:1023-1028.
4. Ellerbrock TV, Chiasson MA, Bush TJ, et al. Incidence of cervical squamous intraepithelial lesions in HIV-infected women. JAMA 2000;283:1031-1037.
5. Duerr A, Paramsothy P, Heilig C, et al. HIV Epidemiology Research Study: Effect of HIV infection on atypical squamous cells of undetermined significance. Clin Infect Dis 2006;42:855-861.
6. Wright TC, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D, for the 2006 American Society for Colposcopy and Cervical Pathology-sponsored Consensus Conference. 2006 Consensus guidelines for the management of women with abnormal cervical screening tests. Am J Obstet Gynecol 2007;197:346-355.
7. Keiser O, Tejada BM, Wunder D, et al. Frequency of gynecologic follow-up and cervical cancer screening in the Swiss HIV Cohort Study. J AIDS 2006;43:550-555.
8. Solomon L, Stein M, Flynn C, et al. Health services use by urban women with or at risk for HIV-1 infection: The HERS Study. J AIDS 1998;17:253-261.
9. Oster AM, Sullivan PS, Blair JM. Prevalence of cervical cancer screening of HIV-infected women in the United States. J Acquir Immune Defic Syndr 2009;51:430-436.
10. Baltimore City Health Department. Ryan White Title I Office Quality Improvement Program Review 2006. Data presented January 2007.
11. Tello M, Yeh HC, Keller JM, Beach MC, Anderson JR, Moore RD. HIV Womens Health: A study of gynecologic healthcare service utilization in a U.S. urban HIV clinic population. J Womens Health 2008;17:1609-1614.
12. Quinn GP, Detman LA, Bell-Ellison BA. Missed appointments in perinatal care: Response variations in quantitative versus qualitative instruments. J Med Pract Manage 2008;23:307-313.
13. Neal RD, Hussain-Gambles M, Allgar VL, Lawlor DA, Dempsey O. Reasons for and consequences of missed appointments in general practice in the UK: Questionnaire survey and prospective review of medical records. BMC Fam Pract 2005;6:47.
14. Catz SL, McClure JB, Jones GN, Brantley PJ. Predictors of outpatient medical appointment attendance among persons with HIV. AIDS Care 1999;11:361-373.
15. Lacy NL, Paulman A, Reuter MD, Lovejoy B. Why we dont come: Patient perceptions on no-shows. Ann Fam Med 2004;2:541-545.
16. McCloskey LA, Williams CM, Lichter E, et al. Abused women disclose partner interference with health care: An unrecognized form of battering. J Gen Intern Med 2007;22: 1067-1072.
17. Rand Organization. Medical outcomes study: Social support survey scoring instructions. Available at www.rand .org=health=surveys-tools=mos=mos- socialsupport-scoring .html Accessed October 2007.
18. Sherbourne CD, Stewart AL. The MOS Social Support Survey. Soc Sci Med 2002;32:705-714.
19. Gaede BM, Majeke SJ, Modeste RRM, Naidoo JR, Titus MJ, Uys LR. Social support and health behavior in women living with HIV in KwaZulu-Natal. Sahara J 2006;3:362-368.
20. Andresen EM, Malmgren JA, Carter WB, Patrick DL. Screening for depression in well older adults: Evaluation of a short form of the CES-D. Am J Prev Med 1994;10:77-84.
21. MacMillan HL, Wathen CN, Jamieson E, et al. Approaches to screening for intimate partner violence in health care settings: A randomized trial. JAMA 2006;296:530-536.
22. Miller WL, Crabtree BF. Qualitative analysis: How to begin making sense. Fam Pract Res J 1994;14:289-297.
23. Franceschi S, Jaffe H. Cervical cancer screening of women living with HIV infection: A must in the era of antiretroviral therapy. Clin Infect Dis 2007;45:510-513.
24. Kojic EM, Cu-Uvin S. Special care issues of women living with HIV-AIDS. Infect Dis Clin North Am 2007;21: 133-148.
25. Bazargan M, Bazargan SH, Farooq M, Baker RS. Correlates of cervical cancer screening among underserved Hispanic and African-American women. Prev Med 2004;39:465-473.
26. Jennings-Dozier K. Perceptual determinants of Pap test upto-date status among minority women. Oncol Nurs Forum 1999;26:1327-1333.
27. Behbakht K, Lynch A, Teal S, Degeest K, Massad S. Social and cultural barriers to Papanicolaou test screening in an urban population. Obstet Gynecol 2004;104:1355-1361.
28. Andrasik MP, Rose R, Pereira D, Antoni M. Barriers to cervical cancer screening among low-income HIV-positive African-American women. J Health Care Poor Underserved 2008;19:912-925.
29. Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Study. Arch Gen Psychiatry 1994;51:8-19.
30. Pence BW, Miller WC, Whetten K, et al. Prevalnce of DSMIV-defined mood, anxiety, and substance use disorders in an HIV clinic in the Southeastern United States. J Acquir Immune Defic Syndr 2006;42:298-306.
31. Holzemer WL, Corless IB, Nokes KM, et al. Predictors of self-reported adherence in persons living with HIV disease. AIDS Patient Care STDs 1999;13:185-197.
32. Gordillo V, del Amo J, Soriano V, et al. Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS 1999;13:1763-1769.
33. Mugavero M, Ostermann J, Whetten K, et al. Barriers to antiretroviral adherence: The importance of depression, abuse, and other traumatic events. AIDS Patient Care STDs 2006;20:418-428.
34. Tucker JS, Burnam MA, Sherbourne CD, et al. Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection. Am J Med 2003;114: 573-580.
35. Cook JA, Grey D, Burke J, et al. Depressive symptoms and AIDS-related mortality among a multisite cohort of HIV-positive women. Am J Public Health 2004;94:1133-1140.
36. Horberg MA, Silverberg MJ, Hurley LB, et al. Effects of depression and selective serotonin reuptake inhibitor use on adherence to highly active antiretroviral therapy and on clinical outcomes in HIV-infected patients. J Acquir Immune Defic Syndr 2008;47:384-390.
37. Rajabiun S, Mallinson RK, McCoy K, et al. "Getting me back on track": The role of outreach interventions and retaining of people living with HIV=AIDS in medical care. AIDS Patient Care STDs. 2007;21:s20-s29.
38. Eggleston KS, Coker AL, Das IP, Cordray ST, Luchok KJ. Understanding barriers for adherence to follow-up care for abnormal Pap tests. J Womens Health 2007;16:311-330.
39. Stein MD, Cunningham WE, Nakazono T, et al., HCSUS Consortium. Screening for cervical cancer in HIV-infected women receiving care in the United States. J AIDS 2001;27: 463-466.